Welcome to our dedicated page for Global Cord Blood SEC filings (Ticker: CORBF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Global Cord Blood Corporation filings document the company's status as a foreign private issuer and the court-supervised provisional liquidation process ordered by the Grand Court of the Cayman Islands in 2022. Recent Form 6-K reports furnish joint provisional liquidator reports and describe Exchange Act current-report disclosures, Form 20-F issuer status, and continuing corporate-status reporting.
Global Cord Blood Corp (CORBF) reports that the Grand Court of the Cayman Islands previously appointed joint provisional liquidators under Section 104(2) of the Cayman Islands Companies Act. The Court appointed Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited as joint provisional liquidators on September 22, 2022.
On September 1, 2026, the joint provisional liquidators furnished their seventeenth report to the Court. This Seventeenth Report, along with all prior reports, is available to stakeholders on the company’s investor relations website and on the Grant Thornton creditor update page.
Global Cord Blood Corporation, which is in provisional liquidation under the supervision of the Grand Court of the Cayman Islands, provided an update on the process to approve fees of the Joint Provisional Liquidators (JPLs). The JPLs have already obtained Court approval of their remuneration and disbursements for two prior periods covering 22 September 2022 to 30 September 2024.
They are now seeking Court sanction of their fees and disbursements for the Third Fee Approval Period, from 1 October 2024 to 30 September 2025, detailed in a Third Fee Report dated 6 August 2026. Because of an ongoing dispute over the Company’s register of members and prior inquorate extraordinary general meetings, the JPLs intend to ask the Court to dispense with the requirement to hold a shareholders’ meeting for this period.
Shareholders may request a copy of the Third Fee Report by emailing evidence of their shareholding to the JPLs and may submit queries about the report by email by 28 August 2026.
Global Cord Blood Corporation, a Cayman Islands company under court-appointed joint provisional liquidation, filed an update about its restructuring process. The Grand Court of the Cayman Islands appointed joint provisional liquidators on September 22, 2022 under Section 104(2) of the Companies Act.
On June 1, 2026, the joint provisional liquidators furnished their sixteenth report to the Court. The report is available on the company’s investor relations website and on Grant Thornton’s creditor update page. The company also lists a regular schedule of earlier reports furnished since October 2022, indicating ongoing court-supervised oversight.
Global Cord Blood Corporation filed an update as a foreign private issuer describing the latest developments in its court-supervised provisional liquidation process in the Cayman Islands. The Grand Court previously appointed joint provisional liquidators (JPLs) for the company under the Cayman Companies Act.
On March 2, 2026, the JPLs submitted their fifteenth report to the Grand Court. The report is available to stakeholders on the company’s investor relations website and on Grant Thornton’s creditor update page. The filing also lists the dates of all prior JPL reports since October 2022, highlighting an ongoing series of structured status updates for creditors and other interested parties.
Global Cord Blood Corporation reports that its court-appointed joint provisional liquidators have submitted their fourteenth report to the Grand Court of the Cayman Islands. The liquidators were originally appointed on September 22, 2022 under the Cayman Islands Companies Act to oversee the Company’s affairs during provisional liquidation.
The new report, dated December 1, 2025, is available to the public on the Company’s investor relations website and on Grant Thornton’s creditor update page. The Company also notes that earlier reports from October 2022 through September 2025 remain accessible, providing an ongoing record of developments in the provisional liquidation process.